奥美拉唑与瑞巴派特治疗药物性胃病比较http://www.100md.com2008年2月1日《中外健康文摘・临床医师》【中图分类号】R573【文献标识码】D【文章编号】1672-5085（2008）02-0136-01
【摘要】目的:评价质子泵抑制剂（PPI）及胃黏膜保护剂治疗NSAIDs所致药物性胃病的临床疗效。方法:分析120例因服NSAIDs引起消化系统症状的病例资料给予质子泵抑制剂（PPI）及胃黏膜保护剂瑞巴派特治疗效果。结果:质子泵抑制剂及胃黏膜保护剂瑞巴派特有明显疗效，其中PPI优于后者。结论:质子泵抑制剂（PPI）治疗NSAIDs所致药物性胃病疗效显著。
【关键词】非甾体抗炎药；药物性胃病；质子泵抑制剂；胃黏膜保护剂
TheAustriaAmericapullssendswiththeSwissPakistanespeciallytotreatthemedicinegastricdiseasetocompareLvHongboZhangGuixiaLiYumei
【Abstract】Objective:Theappraisalprotonpumpstheinhibitor（PPI）andthestomachmucousmembraneprotectingagenttreatsNSAIDstobetheresultofthemedicinegastricdiseaseclinicalcurativeeffect.Method:Analyzes120examplesbecausetotakeNSAIDstocausethedigestingsystemsymptomcaseofillnessmaterialtogivetheprotontopumptheinhibitor（PPI）andthestomachmucousmembraneprotectingagentSwitzerlandPakistansendstheespeciallytreatmentresult.Result：TheprotonpumpstheinhibitorandthestomachmucousmembraneprotectingagentSwitzerlandPakistansendstheuniqueobviouscurativeeffect,PPIsurpasseslatter.Conclusion:Theprotonpumpstheinhibitor（PPI）totreatNSAIDstobetheresultofthemedicinegastricdiseasecurativeeffecttoberemarkable.......
